Senior Software Engineer, 23andMe
Health
$153.6-230.4k
3+ days a week in office (Sunnyvale, CA)
DNA genetic testing for health, ancestry and more
Job no longer available
DNA genetic testing for health, ancestry and more
501-1000 employees
Job no longer available
$153.6-230.4k
3+ days a week in office (Sunnyvale, CA)
501-1000 employees
Company mission
To help people access, understand, and benefit from the human genome.
Jump to section
Company mission
To help people access, understand, and benefit from the human genome.
10% employee growth in 12 months
Our take
23andMe offers its customers a vision into their ancestry and health through genetic testing carried out via kits sent through the mail. Results can show users their risk of more than 100 health conditions thanks to a tube of saliva at one end and a lot of technology at the other.
This access to genetic insight has helped the company sell more than 15 million test kits in the last 15 years. This remains the core component of the business. Access to millions of customers DNA however has given the company a vast collection of genetic material, allowing 23andMe to expanded into the drug development space where it is collaborating with pharmaceutical giant GlaxoSmithKline.
23andMe is not without competition, with other big names including Ancestry and MyHeritage. The company has faced challenges, from weak demand for kits and a failed subscription model to a data breach and bankruptcy. Still, its acquisition by Regeneron in 2025 gives it a fresh star and 23andMe will go on operating, contributing to medical research, while protecting user privacy.
Kirsty
Company Specialist at Welcome to the Jungle
Benefits
- Comprehensive health, vision, and dental plans
- Dog friendly office
- Family planning, support, and leave for parents
- Mental healthcare
- Student loan assistance
- Flexible time off
Funding (last 2 of 10 rounds)
Dec 2020
$82.5m
SERIES F
Jul 2018
$300m
GROWTH EQUITY VC
Total funding: $802.9m
This company has top investors
Leadership
Anne Wojcicki
(Founder & CEO)Anne studied Biology at Yale before working as a Healthcare Analyst for Investor AB, Ardsley Partners, Andor Capital, and Passport Capital for a combined 7 years. They leveraged this clinical experience to found 23andMe in 2006 and have served as the company's CEO since.